Maximized Carbon Flux
Metabolic pathway modification aims to significantly increase the final molar yield of Lactic Acid from the carbon source.
Polylactic Acid (PLA) is a leading bio-based, biodegradable material used across packaging, biomedical, and textile industries. Its widespread adoption is hindered by the current dependence on fermentation, which suffers from low efficiency of lactic acid fermentation and insufficient purity of precursors , leading to a high cost compared to petroleum-derived plastics.
CD Biosynsis offers a synthetic biology service focused on optimizing the microbial production of the PLA precursor, Lactic Acid. Our core strategy involves the modification of the lactic acid metabolism pathway in the host organism to maximize carbon flux towards lactate and minimize byproducts. This is combined with the directed evolution of lactic acid dehydrogenase (LDH) in Escherichia coli to enhance its specific activity, stability, and stereospecificity. This approach aims to establish a cost-effective, high-yield, and high-purity bioproduction route for the PLA building block.
Get a QuoteAchieving cost parity for bio-based PLA requires overcoming these fermentation and enzyme bottlenecks:
A cost-competitive solution must focus on maximizing the flux and purity of the desired Lactic Acid stereoisomer.
CD Biosynsis applies advanced metabolic engineering and enzyme evolution to optimize Lactic Acid production:
Modification of the Lactic Acid Metabolism Pathway
We employ genome editing to knock out competing pathways (e.g., ethanol or acetate pathways) and optimize transport systems to enhance carbon flux toward Lactic Acid.
Directed Evolution of Lactic Acid Dehydrogenase (LDH)
We use molecular evolution techniques to create LDH variants with enhanced specific activity, tolerance to low pH , and improved stereospecificity (L- or D-lactate production).
Cofactor Regeneration Optimization
We tune the host's central metabolism to balance NADH/NAD+ regeneration , a crucial factor for sustained, efficient activity of Lactic Acid Dehydrogenase.
Host Tolerance Engineering
We modify cell membranes or regulatory genes to increase the host's resistance to acidic conditions and high lactate concentrations, allowing for high-titer fermentation.
This systematic approach is focused on optimizing microbial efficiency to produce high-purity Lactic Acid at potentially lower costs.
Our Lactic Acid engineering service is dedicated to pursuing the following production goals:
Maximized Carbon Flux
Metabolic pathway modification aims to significantly increase the final molar yield of Lactic Acid from the carbon source.
High Precursor Purity
Knockout of competing pathways aims to minimize byproducts , simplifying downstream purification steps for polymerization.
Cost Reduction Potential
Higher titer and purity are focused on reducing overall production costs , making bio-PLA more competitive. [Image of Cost Reduction Icon]
Controlled Stereospecificity
Engineered LDH aims to achieve high purity of the desired L- or D-Lactic Acid isomer, which is critical for final PLA material properties .
Robust Host Performance
Tolerance engineering is focused on ensuring the host can perform efficiently under harsh, high-concentration fermentation conditions .
We provide a biosynthetic platform aimed at overcoming the efficiency and cost challenges of Lactic Acid bioproduction for PLA.
Our Lactic Acid strain engineering service follows a standardized, iterative research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding metabolic flux and enzyme performance.
Explore the potential for sustainable, high-purity Lactic Acid production. CD Biosynsis provides customized strain and enzyme engineering solutions:
Why is high purity Lactic Acid critical for PLA?
High Lactic Acid purity is essential because impurities, especially byproducts or residual sugars, can interfere with the polymerization process (ring-opening polymerization of lactide) and negatively affect the molecular weight and final properties of the PLA polymer.
How does stereospecificity affect PLA?
PLA can be made from L- or D-Lactic Acid. Pure L-PLA (PLLA) is crystalline and strong, while pure D-PLA (PDLA) is similar. Mixing them creates stereocomplex PLA , which has a significantly higher melting temperature and increased thermal stability , expanding its industrial uses.
What is the role of the competing pathway knockout?
In many hosts (like E. coli), carbon is naturally converted into multiple products (e.g., acetate, ethanol) to satisfy the cell's energy and growth needs. Knocking out these competing pathways forces the carbon to flow predominantly down the desired Lactic Acid route, increasing yield and purity.
Why is E. coli chosen over natural Lactic Acid bacteria?
E. coli is often chosen because it is genetically well-characterized, has a fast growth rate (high productivity) , and can be engineered to utilize a wider range of low-cost feedstocks (e.g., lignocellulosic sugars) than some traditional Lactic Acid bacteria.
What is the estimated project timeline?
A project involving combined metabolic pathway modification and enzyme directed evolution typically requires 20-24 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.